| Dr Jason Dziak, MD | |
|
509 Biltmore Ave, Asheville, NC 28801 | |
| (828) 213-2250 | |
| (828) 213-2395 |
| Full Name | Dr Jason Dziak |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 27 Years |
| Location | 509 Biltmore Ave, Asheville, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255365227 | NPI | - | NPPES |
| 00026150501 | Other | NY | UNIVERA PROV# |
| 2222 | Other | NY | BLUE SHIELD GROUP# |
| 00372225 | Medicaid | NY | |
| 050081548 | Other | NY | RAILROAD MEDICARE# |
| P010221884 | Other | NY | BLUE CHOICE PROV# |
| MDG325 | Other | NY | PREFERRED CARE |
| 7341237 | Other | NY | AETNA |
| G0189393590 | Other | NY | BLUE CHOICE GROUP# |
| 02168069 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 2008-00095 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Memorial Mission Hospital And Asheville Surgery Ce | Asheville, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mission Health Community Multispecialty Providers Llc | 9537468574 | 577 |
News Archive
NSF International, a public health and safety organization, and Trucost Plc, a global provider of environmental data and analysis, today announced the availability of a new report entitled, Carbon Emissions – Measuring the Risks.
Amgen Inc. today announced results from its first Phase 1/2 study evaluating the safety and efficacy of Nplate® (romiplostim) in children with chronic immune thrombocytopenic purpura (ITP).
After he failed to heed the first big warning about his heart, John Magri was lucky to survive the second.
Genencor, a division of Danisco A/S, today introduced Accellerase® DUET at the Renewable Fuels Association's 15th Annual National Ethanol Conference in Orlando, Fla. This product is the latest generation in the company's line of enzymes used to convert biomass into sugars, a critical step in the production of cellulosic ethanol and other advanced biofuels and biochemicals from non-food feedstocks.
UCLA scientists have identified for the first time a cell-of-origin for human prostate cancer, a discovery that could result in better predictive and diagnostics tools and the development of new and more effective targeted treatments for the disease.
› Verified 3 days ago
| Entity Name | American Anesthesiology Of North Carolina Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033412267 PECOS PAC ID: 2961316450 Enrollment ID: O20031118000860 |
News Archive
NSF International, a public health and safety organization, and Trucost Plc, a global provider of environmental data and analysis, today announced the availability of a new report entitled, Carbon Emissions – Measuring the Risks.
Amgen Inc. today announced results from its first Phase 1/2 study evaluating the safety and efficacy of Nplate® (romiplostim) in children with chronic immune thrombocytopenic purpura (ITP).
After he failed to heed the first big warning about his heart, John Magri was lucky to survive the second.
Genencor, a division of Danisco A/S, today introduced Accellerase® DUET at the Renewable Fuels Association's 15th Annual National Ethanol Conference in Orlando, Fla. This product is the latest generation in the company's line of enzymes used to convert biomass into sugars, a critical step in the production of cellulosic ethanol and other advanced biofuels and biochemicals from non-food feedstocks.
UCLA scientists have identified for the first time a cell-of-origin for human prostate cancer, a discovery that could result in better predictive and diagnostics tools and the development of new and more effective targeted treatments for the disease.
› Verified 3 days ago
| Entity Name | Southeast Anesthesiology Consultants Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538124201 PECOS PAC ID: 7719959873 Enrollment ID: O20040809001398 |
News Archive
NSF International, a public health and safety organization, and Trucost Plc, a global provider of environmental data and analysis, today announced the availability of a new report entitled, Carbon Emissions – Measuring the Risks.
Amgen Inc. today announced results from its first Phase 1/2 study evaluating the safety and efficacy of Nplate® (romiplostim) in children with chronic immune thrombocytopenic purpura (ITP).
After he failed to heed the first big warning about his heart, John Magri was lucky to survive the second.
Genencor, a division of Danisco A/S, today introduced Accellerase® DUET at the Renewable Fuels Association's 15th Annual National Ethanol Conference in Orlando, Fla. This product is the latest generation in the company's line of enzymes used to convert biomass into sugars, a critical step in the production of cellulosic ethanol and other advanced biofuels and biochemicals from non-food feedstocks.
UCLA scientists have identified for the first time a cell-of-origin for human prostate cancer, a discovery that could result in better predictive and diagnostics tools and the development of new and more effective targeted treatments for the disease.
› Verified 3 days ago
| Entity Name | Chs Anesthesia Services Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346649415 PECOS PAC ID: 5799007324 Enrollment ID: O20141209001856 |
News Archive
NSF International, a public health and safety organization, and Trucost Plc, a global provider of environmental data and analysis, today announced the availability of a new report entitled, Carbon Emissions – Measuring the Risks.
Amgen Inc. today announced results from its first Phase 1/2 study evaluating the safety and efficacy of Nplate® (romiplostim) in children with chronic immune thrombocytopenic purpura (ITP).
After he failed to heed the first big warning about his heart, John Magri was lucky to survive the second.
Genencor, a division of Danisco A/S, today introduced Accellerase® DUET at the Renewable Fuels Association's 15th Annual National Ethanol Conference in Orlando, Fla. This product is the latest generation in the company's line of enzymes used to convert biomass into sugars, a critical step in the production of cellulosic ethanol and other advanced biofuels and biochemicals from non-food feedstocks.
UCLA scientists have identified for the first time a cell-of-origin for human prostate cancer, a discovery that could result in better predictive and diagnostics tools and the development of new and more effective targeted treatments for the disease.
› Verified 3 days ago
| Entity Name | Mission Health Community Multispecialty Providers Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457719130 PECOS PAC ID: 9537468574 Enrollment ID: O20160426001883 |
News Archive
NSF International, a public health and safety organization, and Trucost Plc, a global provider of environmental data and analysis, today announced the availability of a new report entitled, Carbon Emissions – Measuring the Risks.
Amgen Inc. today announced results from its first Phase 1/2 study evaluating the safety and efficacy of Nplate® (romiplostim) in children with chronic immune thrombocytopenic purpura (ITP).
After he failed to heed the first big warning about his heart, John Magri was lucky to survive the second.
Genencor, a division of Danisco A/S, today introduced Accellerase® DUET at the Renewable Fuels Association's 15th Annual National Ethanol Conference in Orlando, Fla. This product is the latest generation in the company's line of enzymes used to convert biomass into sugars, a critical step in the production of cellulosic ethanol and other advanced biofuels and biochemicals from non-food feedstocks.
UCLA scientists have identified for the first time a cell-of-origin for human prostate cancer, a discovery that could result in better predictive and diagnostics tools and the development of new and more effective targeted treatments for the disease.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jason Dziak, MD 509 Biltmore Ave, Asheville, NC 28801-4601 Ph: (828) 213-2250 | Dr Jason Dziak, MD 509 Biltmore Ave, Asheville, NC 28801 Ph: (828) 213-2250 |
News Archive
NSF International, a public health and safety organization, and Trucost Plc, a global provider of environmental data and analysis, today announced the availability of a new report entitled, Carbon Emissions – Measuring the Risks.
Amgen Inc. today announced results from its first Phase 1/2 study evaluating the safety and efficacy of Nplate® (romiplostim) in children with chronic immune thrombocytopenic purpura (ITP).
After he failed to heed the first big warning about his heart, John Magri was lucky to survive the second.
Genencor, a division of Danisco A/S, today introduced Accellerase® DUET at the Renewable Fuels Association's 15th Annual National Ethanol Conference in Orlando, Fla. This product is the latest generation in the company's line of enzymes used to convert biomass into sugars, a critical step in the production of cellulosic ethanol and other advanced biofuels and biochemicals from non-food feedstocks.
UCLA scientists have identified for the first time a cell-of-origin for human prostate cancer, a discovery that could result in better predictive and diagnostics tools and the development of new and more effective targeted treatments for the disease.
› Verified 3 days ago
Thomas Broderick Mulford, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 76 Peachtree Rd, Suite 300, Asheville, NC 28803 Phone: 828-274-3477 Fax: 828-274-7407 | |
Everett L Perry, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 76 Peachtree Rd, Suite 300, Asheville, NC 28803 Phone: 828-254-1969 Fax: 828-254-4611 | |
Guy Cavaliere, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 76 Peachtree Rd Ste 300, Asheville, NC 28803 Phone: 828-398-0465 | |
Cecelia Caldwell, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 11 Vanderbilt Park Dr, Asheville, NC 28803 Phone: 828-213-1740 Fax: 828-213-1742 | |
Steven David Roos, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 76 Peachtree Rd, Suite 300, Asheville, NC 28803 Phone: 828-254-1969 Fax: 828-254-4611 | |
Stephen Don Rathburn, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1100 Tunnel Rd, Asheville, NC 28805 Phone: 828-298-7911 | |
Paul J Harris, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 76 Peachtree Road, Suite 300, Asheville, NC 28803 Phone: 828-274-3477 Fax: 828-274-7407 |